| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/25/2001 | WO2001005985A1 Method to modulate the expression of genes inducing the parthenocarpic trait in plants |
| 01/25/2001 | WO2001005984A2 Flavonoid biosynthesis |
| 01/25/2001 | WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | WO2001005982A1 Method for the production of l-amino acids from their racemic n-acetyl-d, l-derivatives by enzymatic racemate cleavage by means of isolated recombinant enzymes |
| 01/25/2001 | WO2001005980A1 Compositions and methods for fumonisin detoxification |
| 01/25/2001 | WO2001005979A1 Process for producing target substance by fermentation method |
| 01/25/2001 | WO2001005978A1 FimH ADHESIN-BASED VACCINES |
| 01/25/2001 | WO2001005977A1 Generation of stable dimers with reversible biotin-binding activity |
| 01/25/2001 | WO2001005976A1 Mutated ribosomal protein l3 |
| 01/25/2001 | WO2001005975A1 MAIZE ORTHOLOGUES OF BACTERIAL RuvB:cDNAS AND USES THEREOF |
| 01/25/2001 | WO2001005974A2 The il-1l1 gene and polypeptide products |
| 01/25/2001 | WO2001005973A1 Macaca cynomolgus il18 |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005971A2 Secreted polypeptides and corresponding polynucleotides |
| 01/25/2001 | WO2001005970A2 Gtp-binding protein associated factors |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005968A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/25/2001 | WO2001005967A1 Splice variants of cd40-receptor |
| 01/25/2001 | WO2001005966A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 01/25/2001 | WO2001005965A1 Non-human mammal with tissue specific modified glucocorticoid receptor |
| 01/25/2001 | WO2001005964A1 Inhibitor of osteoclast precursor formation |
| 01/25/2001 | WO2001005963A2 ANTISENSE OLIGONUCLEOTIDES FOR METABOTROPIC GLUTAMATE RECEPTOR TYPE 1 (mGluR1) |
| 01/25/2001 | WO2001005962A1 Conditional homologous recombination of large genomic vector inserts |
| 01/25/2001 | WO2001005961A1 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
| 01/25/2001 | WO2001005960A1 Process for producing l-amino acid |
| 01/25/2001 | WO2001005959A1 Process for producing target substance by fermentation method |
| 01/25/2001 | WO2001005958A1 Antisense modulation of p13 kinase p110 delta expression |
| 01/25/2001 | WO2001005957A2 Grapevine leafroll-associated virus proteins |
| 01/25/2001 | WO2001005954A1 Antisense modulation of liver glycogen phosphorylase expression |
| 01/25/2001 | WO2001005953A2 Maize ethylene signalling pathway ein3 genes and uses thereof |
| 01/25/2001 | WO2001005952A2 Plant genes |
| 01/25/2001 | WO2001005951A2 Novel sgs3 plant gene and use thereof |
| 01/25/2001 | WO2001005950A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 01/25/2001 | WO2001005947A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | WO2001005945A2 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 01/25/2001 | WO2001005944A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 01/25/2001 | WO2001005940A2 Methods for producing and preparing cells for cell therapy |
| 01/25/2001 | WO2001005939A1 Process for producing target substance by fermentation |
| 01/25/2001 | WO2001005937A2 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | WO2001005936A2 Transformation method and transgenic plants produced thereby |
| 01/25/2001 | WO2001005935A2 Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| 01/25/2001 | WO2001005934A2 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 01/25/2001 | WO2001005875A1 Cationic block copolymers |
| 01/25/2001 | WO2001005835A1 Inactivated vaccine against feline calicivirus disease |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005833A1 Odorant receptors |
| 01/25/2001 | WO2001005832A1 Drug target isogenes: polymorphisms in the dopamine receptor d2 gene |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005830A1 Dna encoding orphan snorf40 receptor |
| 01/25/2001 | WO2001005828A1 Novel human calcium sensitive potassium channel subunits |
| 01/25/2001 | WO2001005827A1 Fima PILUS-BASED VACCINES |
| 01/25/2001 | WO2001005826A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | WO2001005823A2 Tryptase inhibitor |
| 01/25/2001 | WO2001005820A2 Method for down-regulating gdf-8 activity |
| 01/25/2001 | WO2001005808A2 In vitro selection and optional identification of polypeptides using solid support carriers |
| 01/25/2001 | WO2001005802A1 Antisense modulation of fadd expression |
| 01/25/2001 | WO2001005801A1 Novel nucleic acid base pair |
| 01/25/2001 | WO2001005480A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 01/25/2001 | WO2001005435A2 Antisense therapy for hormone-regulated tumors |
| 01/25/2001 | WO2001005432A2 Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
| 01/25/2001 | WO2001005426A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | WO2001005422A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | WO2001005410A1 Neurotropic virus transport |
| 01/25/2001 | WO2001005353A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 01/25/2001 | WO2001005229A1 Non-defective epstein-barr viral vector |
| 01/25/2001 | WO2001005222A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 01/25/2001 | WO2000071566A3 Novel organic anion transport proteins |
| 01/25/2001 | WO2000068399A3 Vector-mediated delivery of integrating transposon sequences |
| 01/25/2001 | WO2000066742A3 Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants |
| 01/25/2001 | WO2000065034A3 Pseudotyped retroviral vector for gene therapy of cancer |
| 01/25/2001 | WO2000064930A3 Tribonectins |
| 01/25/2001 | WO2000061763A3 Proteins related to gaba metabolism |
| 01/25/2001 | WO2000061171A3 Uses of mammalian ox2 protein and related reagents |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000058486A3 Maize ku80 homolog and uses thereof |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000058472A3 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 01/25/2001 | WO2000058465A3 Flint polypeptide analogs |
| 01/25/2001 | WO2000058330A3 Pseudo-cyclic oligonucleobases |
| 01/25/2001 | WO2000057908A3 Attenuated dengue-1 virus vaccine |
| 01/25/2001 | WO2000057837A3 Compositions and methods for effecting the levels of cholesterol |
| 01/25/2001 | WO2000056360A3 Vaccine against antigens from bacteriae |
| 01/25/2001 | WO2000055301A3 Method for inducing viral resistance into a plant |
| 01/25/2001 | WO2000054815A3 Expression of dna or proteins in c. elegans |
| 01/25/2001 | WO2000054580A3 Leukotriene b4 receptor transgenic mammals |
| 01/25/2001 | WO2000053785A3 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins |
| 01/25/2001 | WO2000050616A3 Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells |
| 01/25/2001 | WO2000047728A3 Soybean glutathione-s-transferase enzymes |
| 01/25/2001 | WO2000042196A3 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, cancer, and down's syndrome |
| 01/25/2001 | DE19934720A1 New DNA encoding iron or heavy metal transporters, useful for promoting growth of plants on polluted soil |
| 01/25/2001 | DE19934719A1 New DNA encoding ABC transporters, useful e.g. for promoting growth of plants, particularly legumes on soil polluted with xenobiotics which are normally harmful to the plants |
| 01/25/2001 | DE19934603A1 Regulatorisches Protein pKe#165 aus humanen Keratinozyten Regulatory protein pKe # 165 from human keratinocytes |
| 01/25/2001 | DE19934573A1 Labeling and identifying solid, liquid or gaseous substances, comprises using a complementary pair of nucleic acid sequences for each substance |
| 01/25/2001 | DE19934408A1 New fungal orotic acid phosphoribosyltransferase gene, useful as a selection marker in recombinant protein expression systems |
| 01/25/2001 | DE19933719A1 Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung Structural protein in adeno-associated virus with altered the chromatographic properties, its preparation and use |
| 01/25/2001 | DE19933506A1 Zelluläre Aufnahme von DNA Cellular uptake of DNA |
| 01/25/2001 | DE19930959A1 Neue Antimycotika und Fungizide, Verfahren zu deren Herstellung und Verwendung New antimycotics and fungicides, processes for their preparation and use |
| 01/25/2001 | DE19923950A1 New microorganisms that produce high sulfite levels at a late stage in their growth, useful for producing beer, prevent development of off-flavors by oxidation |
| 01/25/2001 | CA2616704A1 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 01/25/2001 | CA2381961A1 Splice variants of cd40-receptor |